Skip to main content
Aker BioMarine logo

Aker BioMarine — Investor Relations & Filings

Ticker · AKBM ISIN · NO0010886625 LEI · 549300V34T6VWDSYWE64 OL Agriculture, forestry and fishing
Filings indexed 508 across all filing types
Latest filing 2023-11-14 Regulatory Filings
Country NO Norway
Listing OL AKBM

About Aker BioMarine

https://www.akerbiomarine.com/

Aker BioMarine is a biotechnology innovator that sustainably harvests Antarctic krill to develop and supply krill-derived ingredients. The company's core business focuses on producing ingredients for the human health and nutrition markets, including nutraceuticals and dietary supplements. It also serves the aquaculture and animal feed sectors with specialized products. Aker BioMarine leverages its vertically integrated supply chain and scientific research to create a portfolio of products that extends to agricultural biostimulants and pharmaceutical applications. The company is committed to sustainable operations and the scientific validation of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Aker BioMarine to present at Jefferies Healthcare Conference 2023
Regulatory Filings Classification · 99% confidence The document is very short (1035 characters) and announces that the CEO will be speaking at the 'Jefferies Healthcare Conference 2023' and explicitly states, 'Attached you will find the presentation.' This structure—announcing participation in an external event and attaching the presentation material—strongly suggests this filing is an announcement about the presentation itself, rather than the full presentation document (IP) or a general regulatory filing. Since the document is an announcement regarding the publication/availability of presentation materials for an investor event, it fits best under Report Publication Announcement (RPA), which covers announcements about the release of materials, or potentially Investor Presentation (IP) if the attached material is the core content. Given the 'MENU VS MEAL' rule, which favors classifying announcements of reports/presentations as RPA when the text is brief and points to an attachment, RPA is the most appropriate code. If the attached document were provided, IP would be used, but here we only have the announcement wrapper.
2023-11-14 English
Third quarter results for Aker BioMarine
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for Aker BioMarine ASA covering the third quarter of 2023. It includes detailed financial statements (Profit and Loss, Balance Sheet, Cash Flow), management commentary on operational performance, segment analysis, and financial highlights. It is not an announcement of a report, but the report itself, containing substantive financial data for a period shorter than a full fiscal year. Q3 2023
2023-11-01 English
Third quarter results for Aker BioMarine
Interim / Quarterly Report Classification · 100% confidence The document is a 'Third quarter report 2023' for Aker BioMarine. It contains comprehensive financial statements, operational reviews, segment analysis, and financial summaries for the specified period. It is not an announcement of a report (RPA) because it contains the actual financial data and analysis. It is not a 10-K as it covers only the third quarter. Therefore, it is classified as an Interim / Quarterly Report. Q3 2023
2023-11-01 English
Third quarter results for Aker BioMarine
Earnings Release Classification · 98% confidence The document explicitly states it reports on the "Third quarter results for Aker BioMarine" and provides key financial highlights (Revenue, Adjusted EBITDA) for the quarter ending November 1, 2023. This content structure—summarizing period performance, providing management commentary, and outlining an outlook—is characteristic of an Earnings Release (ER). Although it mentions a webcast presentation, the text provided is the initial announcement of the results themselves, not just the announcement of the report's publication (RPA) or a full transcript (CT). It is too brief and focused on highlights to be a comprehensive Interim Report (IR), making ER the most appropriate classification. Q3 2023
2023-11-01 English
Aker BioMarine ASA – Invitation to presentation of the third quarter 2023 results
Report Publication Announcement Classification · 98% confidence The document is an invitation announcing the release date and time (Wednesday 1 November 2023 at 07:00 CET) and subsequent webcast presentation (09:00 CET) for the company's third quarter 2023 results. It explicitly states that the results will be released, and then invites participation in the presentation of those results. Since the document itself is not the full results report (like an IR or ER), but rather an announcement about the upcoming release and presentation, it fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. The document length is short (1463 chars), supporting the RPA classification over the full report classification.
2023-10-30 English
Aker BioMarine ASA – Financial calendar
Report Publication Announcement Classification · 98% confidence The document text explicitly lists a 'Financial calendar' for Aker BioMarine ASA, detailing future dates for various corporate events, including 'Quarterly Report - Q3', 'Annual Report', and 'Annual General Meeting'. It is not the report itself, but rather an announcement about the schedule of future reports and meetings. Since the document announces the publication schedule for reports rather than containing the full content of any specific report (like 10-K or IR), it fits best under the category for announcements regarding the release or publication of company reports. This aligns with the definition of Report Publication Announcement (RPA).
2023-10-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.